CareRx Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA14173C1059
CAD
3.21
0.03 (0.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
CareRx Corp.
WELL Health Technologies Corp.
dentalcorp Holdings Ltd.
Nova Leap Health Corp.
CloudMD Software & Services, Inc.
HealWELL AI, Inc.
Numinus Wellness, Inc.
BioMark Diagnostics, Inc.
Akumin, Inc.
Telo Genomics Corp.
Gemina Laboratories Ltd.

Why is CareRx Corp. ?

1
Healthy long term growth as Net Sales has grown by an annual rate of 16.23%
2
With a growth in Operating Profit of 8.22%, the company declared Outstanding results in Mar 26
  • The company has declared positive results for the last 5 consecutive quarters
  • INTEREST COVERAGE RATIO(Q) Highest at 514.14
  • NET PROFIT(HY) Higher at CAD 25.34 MM
  • ROCE(HY) Highest at 27.51%
3
With ROE of 25.38%, it has a very attractive valuation with a 1.81 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 8.45%, its profits have risen by 2272.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to CareRx Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is CareRx Corp. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
CareRx Corp.
8.45%
89.78
30.78%
S&P/TSX 60
29.6%
2.31
12.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.23%
EBIT Growth (5y)
69.67%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.61
Tax Ratio
0.86%
Dividend Payout Ratio
9.60%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
4.21%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.81
EV to EBIT
17.85
EV to EBITDA
7.37
EV to Capital Employed
1.65
EV to Sales
0.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.24%
ROE (Latest)
25.38%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 514.14

NET PROFIT(HY)

Higher at CAD 25.34 MM

ROCE(HY)

Highest at 27.51%

DEBT-EQUITY RATIO (HY)

Lowest at 56.9 %

DIVIDEND PAYOUT RATIO(Y)

Highest at 107.53%

RAW MATERIAL COST(Y)

Fallen by -4.28% (YoY

DIVIDEND PER SHARE(HY)

Highest at CAD 11.35

OPERATING PROFIT(Q)

Highest at CAD 7.96 MM

OPERATING PROFIT MARGIN(Q)

Highest at 8.48 %

PRE-TAX PROFIT(Q)

Highest at CAD 1.93 MM

-3What is not working for the Company
NET PROFIT(Q)

At CAD 1.3 MM has Fallen at -81.06%

Here's what is working for CareRx Corp.

Interest Coverage Ratio
Highest at 514.14 and Grown
In each period in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Debt-Equity Ratio
Lowest at 56.9 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Profit
Highest at CAD 7.96 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Operating Profit Margin
Highest at 8.48 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CAD 1.93 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Pre-Tax Profit
At CAD 1.93 MM has Grown at 63.61%
over average net sales of the previous four periods of CAD 1.18 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Dividend per share
Highest at CAD 11.35
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CAD)

Dividend Payout Ratio
Highest at 107.53%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -4.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for CareRx Corp.

Net Profit
At CAD 1.3 MM has Fallen at -81.06%
over average net sales of the previous four periods of CAD 6.87 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CAD MM)